Page 22 - Journal of Special Operations Medicine - Summer 2015
P. 22

Treatment of Psoriasis
                                          in the Deployed Setting



                                             Michelle A. Bongiorno, MD;
                                    Shayna C. Rivard, MD; Jon H. Meyerle, MD







          ABSTRACT

          Psoriasis is a chronic immune-mediated disorder that can   and hands. Over the next several weeks, the Sergeant’s
          be triggered by environmental changes, illness, smoking,   battalion deployed and his psoriatic plaques continued
          or medications. This case describes a 25-year-old, active-  to enlarge.
          duty Marine Corps Sergeant with a severe perideploy-
          ment psoriatic flare, and illustrates treatment limitations,   In September 2013, the patient’s treatment regimen was
          restricted access to specialized care, and the importance   changed from triamcinolone to fluocinonide 0.05%
          of mitigating triggers in the deployed setting.    cream, which was to be applied daily to all affected ar-
                                                             eas except his scalp. That week, the patient also started
          Keywords:  psoriasis; psoriasis, plaque; psoriasis, guttate;   taking doxycycline for malaria prophylaxis. Later that
          arthritis, psoriatic; smoking, cessation; ultraviolet light, ex-  month, he continued to have psoriasis progression with
          posure; deployment; military provider              new sites of involvement, including his chest and back
                                                             (Figure 1). At that time, when additional land-based re-
                                                             sources at a nearby Army base were available, the fol-
                                                             lowing regimen was started: scalp: 2 days of mineral oil,
          Introduction
                                                             followed by 1 day of fluocinolone 0.1% oil (both with
          Psoriasis has a bimodal age distribution (20–30 years   occlusion); body: 2 weeks of fluocinonide 0.05% cream
          and 50–60 years) and affects approximately 2% of the   twice daily (with clear-wrap occlusion), then 1 week of
          population worldwide.  Affected individuals have poly-  emollient therapy; and he was additionally counseled
                              1
          genic predisposition plus an environmental trigger (com-  to increase sun exposure via tanning (as tolerated), and
          monly infections, change in environment, medication,   asked to stop smoking.
          psychogenic stress, alcohol consumption, smoking, and
          trauma).  The two most common variants of psoriasis   The Sergeant continued to experience psoriasis flares
                 2–6
          are plaque and guttate psoriasis. Plaque psoriasis com-  and was evaluated in November 2013 by a dermatologist
          monly appears as sharply demarcated, scaly, erythema-
          tous plaques on the elbows, knees, and scalp. Guttate   Figure 1  (Left) Bilateral dorsal hands with multiple mildly
          psoriasis, on the other hand, typically manifests as small   erythematous plaques with overlying, silver scale. (Right)
          discrete papules and plaques, and can be a sequel to an   Right ventral lower extremity with several plaques and
          upper respiratory tract infection. 6–8             smaller discrete erythematous papules. (Below) Multiple
                                                             discrete and coalescing erythematous papules and plaques
                                                             with minimal overlying scale on ventral aspect of trunk.
          Case Report
          A 25-year-old, active-duty Marine Corps Sergeant began
          to form pruritic plaques on his elbows, knees, and hands
          in April 2013. After several months of treatment with
          an over-the-counter lotion, the Sergeant reported for his
          predeployment physical examination (August 2013),
          during which he was first noted to have erythematous,
          scaly plaques on his elbows, knees, bilateral dorsal
          hands, and scalp, in the setting of increased stress due
          to predeployment workups. At that time, he was started
          on coal tar 0.5% shampoo daily to the scalp and tri-
          amcinolone 0.5% cream twice daily to elbows, knees,



                                                          12
   17   18   19   20   21   22   23   24   25   26   27